Light Activated Gels for 3D-Bioprinting with enhanced cell viability and high shape fidelity
Technology Type: Medical device. 
Commercial opportunity: Otago Innovation Ltd is now seeking partners to explore the use of Light Activated Gel (LAG) material.
Synopsis: Light Activated Gels (LAGs) polymerise and harden under visible light. These bio-ink gels can be printed into 3D patterns, and visible light applied to induce rigidity. Previous light-activated hydrogels have relied on toxic compounds and destructive UV light to trigger polymerisation. These new LAGs are much less cytotoxic and do not rely on free radical-generating UV. Putative applications include printing 3-dimensional cellular compartments for drug discovery and modelling drug function in human tissue.
IP status: PCT application: PCT/ NZ2016/050192.
Detailed specifications: Fact sheet (2 page, pdf).
Key contact: Dr Alex Tickle
Commercialisation Manager, Otago Innovation Ltd
Email: alexandra.tickle@otagoinnovation.com
Phone: +64 3 479 4145
